AstraZeneca vaccine safe and effective in new trial data
AstraZeneca’s Covid-19 vaccine developed with Oxford University was 79 per cent effective in preventing symptomatic illness in a large trial in Chile, Peru and...
Alphega launches 60 Covid-19 vaccine centres
Alphega Pharmacy has started delivering Covid-19 vaccinations from 40 independent community pharmacies across England.
An additional 20 pharmacies that belong to the leading European network of...
UK reports new daily vaccine record with 660,276 shots
Britain on Friday (March 19) said it had given 660,276 doses of Covid-19 vaccine in a single day, a new daily record, in a...
PM gets his first dose of AstraZeneca vaccine
Prime Minister Boris Johnson received his first dose of the AstraZeneca Covid-19 vaccine on Friday and urged the public to do the same, saying...
#Pharmacy24 set to promote Covid-19 efforts of pharmacy teams, diversity
This year, #Pharmacy24 will focus on the pharmacy teams’ valuable contribution during the pandemic and on promoting diversity within the sector.
#Pharmacy24 is an annual...
EU’s drug regulator backs ‘safe and effective’ AstraZeneca vaccine
The EU’s drug watchdog said on Thursday it is still convinced the benefits of AstraZeneca’s Covid-19 vaccine outweigh the risks following an investigation into...
NHS gets £6.6bn in additional funding for Covid-19 response and recovery
The government today (March 18) has announced a new funding boost of £7bn for health and social care services, to support the next phase...
UK reports five cases of rare blood clots in AstraZeneca rollout, continues use of shot
Britain’s medicines regulator said there had been five cases of a rare type of blood clot in cerebral veins among people given AstraZeneca’s vaccine...
Shielding set to an end from April 1
Over 3.79 million people in England who are clinically extremely vulnerable will no longer have to shield from April 1 as the number of...
UK vaccine roll-out to be slower than hoped, deliveries to pick up from May
The government said on Thursday that due to lumps and bumps in the global supply chain, vaccine roll-out in the country would be slower...
Current Issue March 2024
